NME1 Antikörper (AA 1-152)
Kurzübersicht für NME1 Antikörper (AA 1-152) (ABIN7596088)
Target
Alle NME1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-152
-
Verwendungszweck
- Human NM23-H1/NME1 antibody
-
Aufreinigung
- protein-A affinity chromatography
-
Immunogen
- Recombinant human NME1 (1-152aa) purified from E. coli
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% glycero
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
-
-
- NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in (NME1))
-
Andere Bezeichnung
- NM23-H1/NME1
-
Hintergrund
- Non-metastatic cells 1 (NME1), also known as NM23-H1, originally identified as a candidate metastasis suppressor gene. NME1 is expressed in different tumor types where their levels have been alternatively associated with reduced or increased metastatic potential. Reductions in NME1 expression have been significantly associated with aggressive behavior in melanoma, breast, colon, and gastric carcinomas. On the contrary, high levels of NME1 gene expression are noted in the advanced stage of thyroid carcinomas.
-
NCBI Accession
- NP_000260
-
Pathways
- Apoptose, Nucleotide Phosphorylation, Carbohydrate Homeostasis, Ribonucleoside Biosynthetic Process
Target
-